Their active center is a conserved tetramer composed of selenocysteine residues (Sec), glutamine (Gln), tryptophan and asparagine
Potential Risks and Gastrointestinal Side Effects Gastrointestinal side effects are the most commonly reported adverse reactions with GLP-1 receptor agonists, occurring in a significant proportion of patients, particularly during treatment initiation and dose escalation
19 A 2023 meta-analysis of six observational studies reported no DR risk associated with GLP-1 RA use
Typically, these digestive side effects range from mild to moderate , are most intense when ramping up your dose, and go away with time as your body gets used to semaglutide
Obesity is a chronic, biologic disease, and different patients need different tools
Patients may find it easier to [keep up] with monthly injections instead of weekly injections, says Jennifer Brown, MD, ABOM, ABFM, Board-certified Obesity Medicine doctor at MyObesityTeam